NCT02325583View on ClinicalTrials.gov

Intraoral 30% Glucose Effect In Newborns

PHASE3CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
EpilepsyHydrocephaly
Interventions
DRUG

30% Glucose

ORAL 30% GLUCOSE 0,5-2 ML

DRUG

Midazolam

INTRAVENOUS 0.1 MG/KG MIDAZOLAM

All Listed Sponsors
lead

Baskent University

OTHER

NCT02325583 - Intraoral 30% Glucose Effect In Newborns | Biotech Hunter | Biotech Hunter